1.3. Dosing in Renal Impairment

Because ivacaftor, lumacaftor/ivacaftor, tezacaftor/ivacaftor, and elexacaftor/tezacaftor/ivacaftor have not been studied in patients with renal insufficiency, these medications should be used cautiously in patients with CrCl less than or equal to 30 mL/min 1-4, 6, 7, 10.